Vissers, L. E. L. M., van Nimwegen, K. J. M., Schieving, J. H., Kamsteeg, E.-J., Kleefstra, T., Yntema, H. G., et al. (2017). A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology. Genetics in Medicine, 19, 1055. https://doi.org/10.1038/gim.2017.1
Article PubMed PubMed Central Google Scholar
Meng, L., Pammi, M., Saronwala, A., Magoulas, P., Ghazi, A. R., Vetrini, F., et al. (2017). Use of exome sequencing for infants in intensive care units: Ascertainment of severe single-gene disorders and effect on medical management. JAMA Pediatrics, 171, e173438. https://doi.org/10.1001/jamapediatrics.2017.3438
Article PubMed PubMed Central Google Scholar
Shickh, S., Mighton, C., Uleryk, E., Pechlivanoglou, P., & Bombard, Y. (2021). The clinical utility of exome and genome sequencing across clinical indications: A systematic review. Human Genetics, 140, 1403–1416. https://doi.org/10.1007/s00439-021-02331-x
Pal, D. K. (1996). Quality of life assessment in children: A review of conceptual and methodological issues in multidimensional health status measures. Journal of Epidemiology and Community Health, 50, 391–396. https://doi.org/10.1136/jech.50.4.391
Article CAS PubMed PubMed Central Google Scholar
Vivier, P. M., Bernier, J. A., & Starfield, B. (1994). Current approaches to measuring health outcomes in pediatric research. Current Opinion in Pediatrics, 6, 530–537. https://doi.org/10.1097/00008480-199410000-00005
Article CAS PubMed Google Scholar
Varni, J. W., Seid, M., & Rode, C. A. (1999). The PedsQL™: Measurement model for the pediatric quality of life inventory. Medical Care, 37, 126–139. https://doi.org/10.1097/00005650-199902000-00003
Article CAS PubMed Google Scholar
Smith, H. S., Ferket, B. S., Gelb, B. D., Hindorff, L., Ferar, K. D., Norton, M. E., et al. (2023). Parent-reported clinical utility of pediatric genomic sequencing. Pediatrics, 152, e2022060318. https://doi.org/10.1542/peds.2022-060318
Krantz, I. D., Medne, L., Weatherly, J. M., Wild, K. T., Biswas, S., NICUSeq Study Group, et al. (2021). Effect of whole-genome sequencing on the clinical management of acutely ill infants with suspected genetic disease: A randomized clinical trial. JAMA Pediatrics, 175, 1218–1226. https://doi.org/10.1001/jamapediatrics.2021.3496
Perry, J., Redfield, S., Oza, A., Rouse, S., Stewart, C., Khela, H., et al. (2022). Exome sequencing expands the genetic diagnostic spectrum for pediatric hearing loss. The Laryngoscope. https://doi.org/10.1002/lary.30507
Article PubMed PubMed Central Google Scholar
Haviland, I., Daniels, C. I., Greene, C. A., Drew, J., Love-Nichols, J. A., Swanson, L. C., et al. (2023). Genetic diagnosis impacts medical management for pediatric epilepsies. Pediatric Neurology, 138, 71–80. https://doi.org/10.1016/j.pediatrneurol.2022.10.006
Ayres, S., Gallacher, L., Stark, Z., & Brett, G. R. (2019). Genetic counseling in pediatric acute care: Reflections on ultra-rapid genomic diagnoses in neonates. Journal of Genetic Counseling, 28, 273–282. https://doi.org/10.1002/jgc4.1086
Smith, H. S., Swint, J. M., Lalani, S. R., Yamal, J.-M., de Oliveira Otto, M. C., Castellanos, S., et al. (2019). Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: A scoping review of the literature. Genetics in Medicine, 21, 3–16. https://doi.org/10.1038/s41436-018-0024-6
Article CAS PubMed Google Scholar
Callahan, K. P., Mueller, R., Flibotte, J., Largent, E. A., & Feudtner, C. (2022). Measures of utility among studies of genomic medicine for critically ill infants: A systematic review. JAMA Network Open, 5, e2225980–e2225980. https://doi.org/10.1001/jamanetworkopen.2022.25980
Article PubMed PubMed Central Google Scholar
Grosse, S. D., & Khoury, M. J. (2006). What is the clinical utility of genetic testing? Genetics in Medicine, 8, 448–450. https://doi.org/10.1097/01.gim.0000227935.26763.c6
Foster, M. W., Mulvihill, J. J., & Sharp, R. R. (2009). Evaluating the utility of personal genomic information. Genetics in Medicine, 11, 570–574.
Hayeems, R. Z., Luca, S., Ungar, W. J., Venkataramanan, V., Tsiplova, K., Bashir, N. S., et al. (2022). The clinician-reported genetic testing utility InDEx (C-GUIDE): Preliminary evidence of validity and reliability. Genetics in Medicine, 24, 430–438. https://doi.org/10.1016/j.gim.2021.10.005
Article CAS PubMed Google Scholar
Hayeems, R. Z., Dimmock, D., Bick, D., Belmont, J. W., Green, R. C., Lanpher, B., et al. (2020). Clinical utility of genomic sequencing: A measurement toolkit. NPJ Genomic Medicine, 5, 1–11.
Green, R. C., Shah, N., Genetti, C. A., Yu, T., Zettler, B., Uveges, M. K., et al. (2023). Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. American Journal of Human Genetics, 110, 1034–1045. https://doi.org/10.1016/j.ajhg.2023.05.007
Article CAS PubMed PubMed Central Google Scholar
Linder, J. E., Tao, R., Chung, W. K., Kiryluk, K., Liu, C., Weng, C., et al. (2023). Prospective, multi-site study of healthcare utilization after actionable monogenic findings from clinical sequencing. American Journal of Human Genetics, 110, 1950–1958. https://doi.org/10.1016/j.ajhg.2023.10.006
Article CAS PubMed Google Scholar
Kohler, J. N., Turbitt, E., Lewis, K. L., Wilfond, B. S., Jamal, L., Peay, H. L., et al. (2017). Defining personal utility in genomics: A Delphi study. Clinical Genetics, 92, 290–297. https://doi.org/10.1111/cge.12998
Article CAS PubMed PubMed Central Google Scholar
Smith, H. S., Brothers, K. B., Knight, S. J., Ackerman, S. L., Rini, C., Veenstra, D. L., et al. (2021). Conceptualization of utility in translational clinical genomics research. American Journal of Human Genetics. https://doi.org/10.1016/j.ajhg.2021.08.013
Article PubMed PubMed Central Google Scholar
Smith, H. S., Morain, S. R., Robinson, J. O., Canfield, I., Malek, J., Rubanovich, C. K., et al. (2022). Perceived utility of genomic sequencing: Qualitative analysis and synthesis of a conceptual model to inform patient-centered instrument development. Patient - Patient-Centered Outcomes Research, 15, 317–328. https://doi.org/10.1007/s40271-021-00558-4
Turbitt, E., Kohler, J. N., Angelo, F., Miller, I. M., Lewis, K. L., Goddard, K. A. B., et al. (2023). The PrU: Development and validation of a measure to assess personal utility of genomic results. Genetics in Medicine, 25, 100356. https://doi.org/10.1016/j.gim.2022.12.003
Article CAS PubMed Google Scholar
Buchanan, J., & Wordsworth, S. (2019). Evaluating the outcomes associated with genomic sequencing: A roadmap for future research. PharmacoEconomics - Open, 3, 129–132. https://doi.org/10.1007/s41669-018-0101-4
Ow, N., & Mayo, N. E. (2020). Health-related quality of life scores of typically developing children and adolescents around the world: A meta-analysis with meta-regression. Quality of Life Research, 29, 2311–2332. https://doi.org/10.1007/s11136-020-02519-0
Pinquart, M. (2020). Health-related quality of life of young people with and without chronic conditions. Journal of Pediatric Psychology, 45, 780–792. https://doi.org/10.1093/jpepsy/jsaa052
Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQLTM 4.0: Reliability and validity of the pediatric quality of life InventoryTM Version 4.0 generic core scales in healthy and patient populations. Medical Care, 39, 800–812. https://doi.org/10.1097/00005650-200108000-00006
Article CAS PubMed Google Scholar
Varni, J. W., Limbers, C. A., Neighbors, K., Schulz, K., Lieu, J. E. C., Heffer, R. W., et al. (2011). The PedsQL™ Infant Scales: Feasibility, internal consistency reliability, and validity in healthy and ill infants. Quality of Life Research, 20, 45–55. https://doi.org/10.1007/s11136-010-9730-5
Desai, A. D., Zhou, C., Stanford, S., Haaland, W., Varni, J. W., & Mangione-Smith, R. M. (2014). Validity and responsiveness of the pediatric quality of life inventory (PedsQL) 4.0 generic core scales in the pediatric inpatient setting. JAMA Pediatrics, 168, 1114. https://doi.org/10.1001/jamapediatrics.2014.1600
Varni, J. W., Burwinkle, T. M., Seid, M., & Skarr, D. The PedsQL* 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambul Pediatr n.d.
Varni, J. W., Limbers, C. A., & Burwinkle, T. M. (2007). How young can children reliably and validly self-report their health-related quality of life? An analysis of 8,591 children across age subgroups with the PedsQLTM 4.0 Generic Core Scales. Health and Quality of Life Outcomes, 5, 1. https://doi.org/10.1186/1477-7525-5-1
Article PubMed PubMed Central Google Scholar
Varni, J. W., Limbers, C. A., & Burwinkle, T. M. (2007). Parent proxy-report of their children’s health-related quality of life: An analysis of 13,878 parents’ reliability and validity across age subgroups using the PedsQLTM 4.0 Generic Core Scales. Health and Quality of Life Outcomes, 5, 2. https://doi.org/10.1186/1477-7525-5-2
Article PubMed PubMed Central Google Scholar
Splinter, K., Niemi, A.-K., Cox, R., Platt, J., Shah, M., Enns, G. M., et al. (2016). Impaired health-related quality of life in children and families affected by methylmalonic acidemia. Journal of Genetic Counseling, 25, 936–944.
Vanz, A. P., van de Sande, L. J., Pinheiro, B., Zambrano, M., Brizola, E., da Rocha, N. S., et al. (2018). Health-related quality of life of children and adolescents with osteogenesis imperfecta: A cross-sectional study using PedsQL™. BMC Pediatrics, 18, 95.
留言 (0)